Skip to main content
. 2013 Jan 8;18(1):54–63. doi: 10.1634/theoncologist.2012-0050

Table 1.

Number of studies reporting effectiveness and safety outcomes by chemotherapy type

graphic file with name onc00113-1228-t01.jpg

aCombination of various chemotherapy regimens not broken down by agent.

Abbreviations: 5-FU/LV, 5-fluorouracil and leucovorin; Bev, bevacizumab; Cap, capecitabine; CapeOx, capecitabine and oxaliplatin; FOLFOX, 5-fluorouracil, leucovorin, and oxaliplatin; Iri, irinotecan; LV, leucovorin.